Key facts
- This page summarizes Ilene R. Baylinson's Form 4 filing for MAXIMUS, INC. (MMS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Oct 2026, 16:55.
Ilene R. Baylinson - 30 Sep 2026 Form 4 Insider Report for MAXIMUS, INC. (MMS)
- Reporting relationship
- General Mgr - Health & Human
- Issuer ticker
- MMS
- Reported as of
- 30 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Oct 2026, 16:55:53 UTC
- Prior SEC filing
- 03 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jason Frank: As Attorney-In-Fact for: Ilene Baylinson
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Ilene R. Baylinson filed Form 4 for MAXIMUS, INC. (MMS) on 02 Oct 2026.
Change
- Previous filing in this sequence was filed on 03 Dec 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001791080
Primary reporting owner
Baylinson Ilene R.
- Relationship
- General Mgr - Health & Human
- Address
- C/O MAXIMUS INC., 1600 TYSONS BLVD, STE 1400, MCLEAN
- Signature
- /s/ Jason Frank: As Attorney-In-Fact for: Ilene Baylinson
- Signature date
- 02 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MMS
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -3,945
- Change %
- -15%
- Price
- $53.19*
- Shares after
- 21,689
- Date
- 30 Sep 2026
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These shares were surrendered to satisfy the withholding tax due in connection with the vesting of restricted stock units ("RSUs").
Footnote F2
Includes 240.271 dividend equivalents accrued on unvested RSUs since the reporting person's last Form 4 filing.